Faruqi & Faruqi Investigates Inspire Medical Systems for Shareholders

Shareholder Action Reminder

Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently looking into possible claims against Inspire Medical Systems, Inc. This investigation comes in response to troubling developments concerning the company's financial health and market activities. Investors who purchased stocks in Inspire between August 6, 2024, and August 4, 2025, may have legal options available to them.

The firm reminds investors of a pressing deadline: January 5, 2026, marks the final date to apply for lead plaintiff roles in a federal securities class action lawsuit against Inspire Medical. Potential plaintiffs are encouraged to reach out directly to James (Josh) Wilson from Faruqi & Faruqi to discuss their circumstances and options.

This investigation follows Inspire Medical's recent disclosures revealing setbacks in the launch of its new Inspire V device. On August 4, 2025, the company announced that the launch faced significant delays due to various logistical challenges—namely, that several treatment centers had not yet completed the training and onboarding necessary to initiate the use of the new device. Moreover, Inspire disclosed complexities involving billing and reimbursements; a newly approved CPT code for Inspire V from Medicare wouldn't take effect until July 1, creating a backlog for institutions still employing the older Inspire IV system.

Beyond these training and billing complications, Inspire Medical cited dismal demand and excessive inventory issues affecting the Inspire V roll out. This culmination of negative indicators triggered a drastic financial forecast revision, forcing the company to slash its earnings guidance for 2025 by over 80%. Investors responded to this news with alarm, resulting in a steep drop of about 32% in Inspire's stock price in just one trading day—from $129.95 per share on August 4, 2025, to $87.91 the following day, erasing roughly $1.2 billion in its total market cap.

As the details of this case unfold, Faruqi & Faruqi emphasizes the importance of collective legal action, especially for those who have encountered financial losses due to alleged misconduct by Inspire Medical. A lead plaintiff, that person who holds the most significant stake in the case, will guide the litigation on behalf of all affected investors. Any investor considering this path may consult with their legal representatives or may decide to simply observe the proceedings as non-participating class members.

Faruqi & Faruqi extends a call for whistleblowers, former employees, and any others with pertinent information regarding Inspire Medical's operations to come forward and assist in constructing a clearer picture of the company's practices during this tumultuous period.

For more information on the class-action process regarding Inspire Medical or to initiate communication about potential claims, investors may visit Faruqi & Faruqi’s website or directly contact Josh Wilson at the provided numbers. As the firm navigates this complex landscape, it remains dedicated to fostering transparency and accountability for shareholders who have suffered as a result of the company's actions.

It's vital in situations like these for investors to remain informed and proactive, as the outcomes could significantly impact their financial futures. By staying engaged with ongoing legal developments, and if warranted, joining the class action, shareholders can advocate for necessary changes and potential compensation for losses incurred. Follow the firm's updates through platforms like LinkedIn and X for real-time information on this investigation and other securities-related news.

Attorney Advertising: The law firm associated with this notice is Faruqi & Faruqi, LLP. Previous results do not guarantee similar outcomes in future matters. All discussions will be handled with confidentiality in mind.